60505-3801Level 3
Nilotinib (nilotinib)
**Product type:** Human Prescription Drug
**Active ingredient:** NILOTINIB
**Strength:** 150 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Apotex Corp.
**Marketing category:** ANDA (ANDA203640)
**Pharmacologic class:** Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/60505-3801Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.